Gene · 8030
Papers1,913
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,913
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial. | J Clin Oncol | 2023 | 36122315 | PubTator, text mining | PubMed |
| The genomic characteristics of RET fusion positive tumors in Chinese non-small cell lung cancer (NSCLC) patients. | J Cancer Res Clin Oncol | 2023 | 35220468 | PubTator, text mining | PubMed |
| Durable Disease Control by RET Inhibitor Selpercatinib in a Heavily Pre-Treated RET Fusion-Positive Papillary Thyroid Cancer. | Case Rep Oncol | 2022 | 36825106 | PubTator, text mining | PubMed |
| Implications of BRAF V600E mutation in gliomas: Molecular considerations, prognostic value and treatment evolution. | Front Oncol | 2022 | 36686797 | PubTator, text mining | PubMed |
| Maximizing Small Biopsy Patient Samples: Unified RNA-Seq Platform Assessment of over 120,000 Patient Biopsies. | J Pers Med | 2022 | 36675685 | PubTator, text mining | PubMed |
| From targeted therapy to a novel way: Immunogenic cell death in lung cancer. | Front Med (Lausanne) | 2022 | 36619616 | PubTator, text mining | PubMed |
| Risk of malignancy in cytologically indeterminate thyroid nodules harboring thyroid stimulating hormone receptor mutations. | Front Endocrinol (Lausanne) | 2022 | 36619548 | PubTator, text mining | PubMed |
| Activation of cancer immunotherapy by nanomedicine. | Front Pharmacol | 2022 | 36618938 | PubTator, text mining | PubMed |
| Targeted Therapy for Anaplastic Thyroid Carcinoma: Advances and Management. | Cancers (Basel) | 2022 | 36612173 | PubTator, text mining | PubMed |
| The Intention of Retail Stores in Taiwan to Cooperate with the Government in the Establishment of IT Measures for Pandemic Prevention. | Healthcare (Basel) | 2022 | 36611490 | PubTator, text mining | PubMed |
| Clinically relevant fusion oncogenes: detection and practical implications. | Ther Adv Med Oncol | 2022 | 36601633 | PubTator, text mining | PubMed |
| Detection of ROS1 gene fusions using next-generation sequencing for patients with malignancy in China. | Front Cell Dev Biol | 2022 | 36589752 | PubTator, text mining | PubMed |
| Association of Programmed Death-Ligand 1 Expression with Aggressive Histological Types of Thyroid Carcinoma. | Cancer Manag Res | 2022 | 36583030 | PubTator, text mining | PubMed |
| Targeted therapy of RET fusion-positive non-small cell lung cancer. | Front Oncol | 2022 | 36582799 | PubTator, text mining | PubMed |
| Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma. | Front Oncol | 2022 | 36578928 | PubTator, text mining | PubMed |
| Precious Gene: The Application of RET-Altered Inhibitors. | Molecules | 2022 | 36557971 | PubTator, text mining | PubMed |
| The Impact of Taste Preference-Related Gene Polymorphisms on Alcohol Consumption Behavior: A Systematic Review. | Int J Mol Sci | 2022 | 36555636 | PubTator, text mining | PubMed |
| Therapeutic Applications for Oncolytic Self-Replicating RNA Viruses. | Int J Mol Sci | 2022 | 36555262 | PubTator, text mining | PubMed |
| Intraoperative Assessment of High-Risk Thyroid Nodules Based on Electrical Impedance Measurements: A Feasibility Study. | Diagnostics (Basel) | 2022 | 36552958 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8030/papers?page=18